What is the ticker symbol for OncoCyte?

OncoCyte trades under the ticker OCX on NASDAQ.

What sector does OncoCyte operate in?

OncoCyte is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OCX in a portfolio?

PortView shows OCX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

OncoCyte (OCX) Stock Analysis

NASDAQHealthcareBiotechnology

$3.20+17.22%

1-year price historyRange $1.96 – $4.24

52-week range$3.20

$1.92$4.75

What OncoCyte does

OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.

Key metrics

Market cap

$91.52M

P/E (TTM)

-0.84

EPS (TTM)

$-3.79

Beta

0.99

Dividend yield

0.00%

Revenue / share

$0.05

50-day avg

$3.03

200-day avg

$2.80

52-week high

$4.75

52-week low

$1.92

CEO

Joshua Riggs

ETFs linked to OCX

Broad-market and Healthcare sector ETFs an investor holding OncoCyte is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OCX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OCX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for OncoCyte?: OncoCyte trades under the ticker OCX on NASDAQ.
Which exchange is OCX listed on?: OCX is listed on NASDAQ.
What sector does OncoCyte operate in?: OncoCyte is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OCX in a portfolio?: PortView shows OCX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.